Rosilene Cardoso

Rosilene Cardoso


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2016 in Molecules
Verified
Journal Article
Open access
PDF file
KBKarine Zanoli Bernuci
Karine Zanoli Bernuci
CICamila Iwanaga
Camila Iwanaga
CFCarla Maria Mariano Fernandez-Andrade
Carla Maria Mariano Fernandez-Andrade
FLFabiana Brusco Lorenzetti
Fabiana Brusco Lorenzetti
ETEduardo Caio Torres-Santos
Eduardo Caio Torres-Santos
DCDiogenes Cortez
Diogenes Cortez
Essential oils from fresh Piperaceae leaves were obtained by hydrodistillation and analyzed by gas chromatography mass spectrometry (GC–MS), and a total of 68 components were identified. Principal components analysis results showed a chemical variability between species, with sesquiterpene compounds predominating in the majority of species analyzed. The composition of the essential oil of Piper mosenii was described for the first time. The cytotoxicity of the essential oils was evaluated in peritoneal macrophages and the oils of P. rivinoides, P. arboretum, and P. aduncum exhibited the highest values, with cytotoxic concentration at 50% (CC50) > 200 µg/mL. Both P. diospyrifolium and P. aduncum displayed activity against Leishmania amazonensis, and were more selective for the parasite than for the macrophages, with a selectivity index (SI) of 2.35 and >5.52, respectively. These SI values were greater than the 1 for the standard drug pentamidine. The antileishmanial activity of the essential oils of P. diospyrifolium and P. aduncum was described for the first time. P. rivinoides, P. cernuum, and P. diospyrifolium displayed moderate activity against the Mycobacterium tuberculosis H37Rv bacillus, with a minimum inhibitory concentration (MIC) of 125 µg/mL. These results are relevant and suggests their potential for therapeutic purposes. Nevertheless, further studies are required to explain the exact mechanism of action of these essential oils.

1 March 2016 in Tuberculosis
Verified
Journal Article
Closed access
KCKatiany R Caleffi-Ferracioli
Katiany R Caleffi-Ferracioli
RARenata Claro R. Amaral
Renata Claro R. Amaral
FDFernanda O. Demitto
Fernanda O. Demitto
FMFlaviane G. Maltempe
Flaviane G. Maltempe
PCPedro Henrique Canezin
Pedro Henrique Canezin
RCRosilene Cardoso
Rosilene Cardoso

1 January 2018 in Research in Microbiology
Verified
Journal Article
Closed access
ASAlex Fiori Silva
Alex Fiori Silva
ASAdriele Rodrigues Dos Santos
Adriele Rodrigues Dos Santos
DTDaliah Alves Coelho Trevisan
Daliah Alves Coelho Trevisan
Alessandra Braga RibeiroAlessandra Braga Ribeiro
Alessandra Braga Ribeiro
PCPaula Aline Zanetti Campanerut-Sá
Paula Aline Zanetti Campanerut-Sá
JMJane Martha Graton Mikcha
Jane Martha Graton Mikcha

1 April 2015 in Journal of Microbiological Methods
Verified
Journal Article
Closed access
ACAline Lemes Castilho
Aline Lemes Castilho
KCKatiany Rizzieri Caleffi-Ferracioli
Katiany Rizzieri Caleffi-Ferracioli
PCPedro Henrique Canezin
Pedro Henrique Canezin
VSVera Lúcia Dias Siqueira
Vera Lúcia Dias Siqueira
RSRegiane Bertin de Lima Scodro
Regiane Bertin de Lima Scodro
RCRosilene Cardoso
Rosilene Cardoso

1 December 2016 in Journal of Microbiology, Immunology and Infection
Verified
Journal Article
Open access
APAline Daniele Furlan Pagliotto
Aline Daniele Furlan Pagliotto
KCKatiany Rizzieri Caleffi-Ferracioli
Katiany Rizzieri Caleffi-Ferracioli
MLMariana Aparecida Lopes
Mariana Aparecida Lopes
VBVanessa Pietrowski Baldin
Vanessa Pietrowski Baldin
CLClarice Queico Fujimura Leite
Clarice Queico Fujimura Leite
RCRosilene Cardoso
Rosilene Cardoso
We report the in vitro drugs interaction by the resazurin drugs combination microtiter assay (REDCA) of amoxicillin (AMO)/clavulanate (CLAV) with isoniazid (INH), ethambutol (EMB), and rifampicin (RIF) against susceptible and resistant Mycobacterium tuberculosis isolates. The addition of AMO/CLAV to classical antituberculosis drugs should be explored as a promising alternative for the treatment of resistant tuberculosis (TB).

20 November 2020 in Future Microbiology
Verified
Journal Article
Closed access
BFBeatriz C de Freitas
Beatriz C de Freitas
PQPaula A Queiroz
Paula A Queiroz
VBVanessa P Baldin
Vanessa P Baldin
PAPedro Hr Do Amaral
Pedro Hr Do Amaral
LRLucas Lf Rodrigues
Lucas Lf Rodrigues
VSVera Ld Siqueira
Vera Ld Siqueira
Aim: To evaluate the activity of (-)-camphene-based thiosemicarbazide (TSC) and 4-hydroxy-thiosemicarbazone (4-OH-TSZ), alone and in combination against Gram-positive. Material & methods: MIC were ...